305 related articles for article (PubMed ID: 31149644)
21. Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.
Pham K; Maxwell MJ; Sweeney H; Alt J; Rais R; Eberhart CG; Slusher BS; Raabe EH
J Neuropathol Exp Neurol; 2021 Mar; 80(4):336-344. PubMed ID: 33712838
[TBL] [Abstract][Full Text] [Related]
22. A Supplemented High-Fat Low-Carbohydrate Diet for the Treatment of Glioblastoma.
Martuscello RT; Vedam-Mai V; McCarthy DJ; Schmoll ME; Jundi MA; Louviere CD; Griffith BG; Skinner CL; Suslov O; Deleyrolle LP; Reynolds BA
Clin Cancer Res; 2016 May; 22(10):2482-95. PubMed ID: 26631612
[TBL] [Abstract][Full Text] [Related]
23. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors:
Artzi M; Liberman G; Vaisman N; Bokstein F; Vitinshtein F; Aizenstein O; Ben Bashat D
J Neurooncol; 2017 Apr; 132(2):267-275. PubMed ID: 28074323
[TBL] [Abstract][Full Text] [Related]
24. Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy.
Poff AM; Ward N; Seyfried TN; Arnold P; D'Agostino DP
PLoS One; 2015; 10(6):e0127407. PubMed ID: 26061868
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model.
Morscher RJ; Aminzadeh-Gohari S; Feichtinger RG; Mayr JA; Lang R; Neureiter D; Sperl W; Kofler B
PLoS One; 2015; 10(6):e0129802. PubMed ID: 26053068
[TBL] [Abstract][Full Text] [Related]
26. A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth.
De Feyter HM; Behar KL; Rao JU; Madden-Hennessey K; Ip KL; Hyder F; Drewes LR; Geschwind JF; de Graaf RA; Rothman DL
Neuro Oncol; 2016 Aug; 18(8):1079-87. PubMed ID: 27142056
[TBL] [Abstract][Full Text] [Related]
27. Glucose reduces the anticonvulsant effects of the ketogenic diet in EL mice.
Mantis JG; Meidenbauer JJ; Zimick NC; Centeno NA; Seyfried TN
Epilepsy Res; 2014 Sep; 108(7):1137-44. PubMed ID: 24938543
[TBL] [Abstract][Full Text] [Related]
28. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.
Maalouf M; Rho JM; Mattson MP
Brain Res Rev; 2009 Mar; 59(2):293-315. PubMed ID: 18845187
[TBL] [Abstract][Full Text] [Related]
29. Metabolic management of brain cancer.
Seyfried TN; Kiebish MA; Marsh J; Shelton LM; Huysentruyt LC; Mukherjee P
Biochim Biophys Acta; 2011 Jun; 1807(6):577-94. PubMed ID: 20804725
[TBL] [Abstract][Full Text] [Related]
30. A redox-responsive prodrug for tumor-targeted glutamine restriction.
Prange CJ; Sayed NYB; Feng B; Goepfert C; Trujillo DO; Hu X; Tang L
J Control Release; 2024 Apr; 368():251-264. PubMed ID: 38403173
[TBL] [Abstract][Full Text] [Related]
31. ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma.
Voss M; Wagner M; von Mettenheim N; Harter PN; Wenger KJ; Franz K; Bojunga J; Vetter M; Gerlach R; Glatzel M; Paulsen F; Hattingen E; Baehr O; Ronellenfitsch MW; Fokas E; Imhoff D; Steinbach JP; Rödel C; Rieger J
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):987-995. PubMed ID: 32619561
[TBL] [Abstract][Full Text] [Related]
32. We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of
Lemberg KM; Vornov JJ; Rais R; Slusher BS
Mol Cancer Ther; 2018 Sep; 17(9):1824-1832. PubMed ID: 30181331
[TBL] [Abstract][Full Text] [Related]
33. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria.
Gordon EB; Hart GT; Tran TM; Waisberg M; Akkaya M; Kim AS; Hamilton SE; Pena M; Yazew T; Qi CF; Lee CF; Lo YC; Miller LH; Powell JD; Pierce SK
Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13075-80. PubMed ID: 26438846
[TBL] [Abstract][Full Text] [Related]
34. Reduced glucose utilization underlies seizure protection with dietary therapy in epileptic EL mice.
Meidenbauer JJ; Roberts MF
Epilepsy Behav; 2014 Oct; 39():48-54. PubMed ID: 25200525
[TBL] [Abstract][Full Text] [Related]
35. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.
Piao L; Fang YH; Parikh K; Ryan JJ; Toth PT; Archer SL
J Mol Med (Berl); 2013 Oct; 91(10):1185-97. PubMed ID: 23794090
[TBL] [Abstract][Full Text] [Related]
36. Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.
Manivannan S; Baxter VK; Schultz KL; Slusher BS; Griffin DE
J Virol; 2016 Oct; 90(20):9251-62. PubMed ID: 27489275
[TBL] [Abstract][Full Text] [Related]
37. Toward a cancer-specific diet.
Bozzetti F; Zupec-Kania B
Clin Nutr; 2016 Oct; 35(5):1188-95. PubMed ID: 25707910
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory Effect of a Glutamine Antagonist on Proliferation and Migration of VSMCs via Simultaneous Attenuation of Glycolysis and Oxidative Phosphorylation.
Park HY; Kim MJ; Lee S; Jin J; Lee S; Kim JG; Choi YK; Park KG
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070527
[TBL] [Abstract][Full Text] [Related]
39. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.
Champ CE; Palmer JD; Volek JS; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Shi W
J Neurooncol; 2014 Mar; 117(1):125-31. PubMed ID: 24442482
[TBL] [Abstract][Full Text] [Related]
40. Mammalian Target of Rapamycin 2 (MTOR2) and C-MYC Modulate Glucosamine-6-Phosphate Synthesis in Glioblastoma (GBM) Cells Through Glutamine: Fructose-6-Phosphate Aminotransferase 1 (GFAT1).
Liu B; Huang ZB; Chen X; See YX; Chen ZK; Yao HK
Cell Mol Neurobiol; 2019 Apr; 39(3):415-434. PubMed ID: 30771196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
